Loring Wolcott & Coolidge Fiduciary Advisors LLP Boston Scientific Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $11.2 Billion
- Q3 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 9,608 shares of BSX stock, worth $986,645. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,608
Previous 1,233
679.24%
Holding current value
$986,645
Previous $132,000
610.61%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BSX
# of Institutions
1,951Shares Held
1.26BCall Options Held
10.9MPut Options Held
8.94M-
Vanguard Group Inc Valley Forge, PA138MShares$14.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.9MShares$6.67 Billion0.23% of portfolio
-
Bank Of America Corp Charlotte, NC33.9MShares$3.48 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA33.1MShares$3.4 Billion2.56% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...